Cargando…
In-silico investigation of a novel inhibitors against the antibiotic-resistant Neisseria gonorrhoeae bacteria
Antibiotics are drugs that are used to treat or prevent bacterial infections. They work by either killing or stopping bacteria from spreading. Nevertheless, it appeared in the last decade, Antibiotic-resistant bacteria are bacteria resistant to antibiotics and cannot be controlled or killed by them....
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460163/ https://www.ncbi.nlm.nih.gov/pubmed/36091725 http://dx.doi.org/10.1016/j.sjbs.2022.103424 |
_version_ | 1784786679858462720 |
---|---|
author | Mohammed Ali, Hani |
author_facet | Mohammed Ali, Hani |
author_sort | Mohammed Ali, Hani |
collection | PubMed |
description | Antibiotics are drugs that are used to treat or prevent bacterial infections. They work by either killing or stopping bacteria from spreading. Nevertheless, it appeared in the last decade, Antibiotic-resistant bacteria are bacteria resistant to antibiotics and cannot be controlled or killed by them. In the presence of an antibiotic, they can live and even reproduce. The Neisseria gonorrhoeae bacteria is appearing to be a multidrug-resistant pathogen. Many factors contribute to antibiotic resistance, including unfettered access to antimicrobials, incorrect drug selection, misuse, and low-quality antibiotics. Here, we investigated in-silico docking screening and analysis for ten natural marine fungus extracted compounds. The resulted data were examined for the best binding affinity, toxicity, and chemical interactions. The most superior compound was elipyrone A with six hydrogen bonds, −8.5 of binding affinity, and preferable results in the SWISS-ADME examination. It is well known that “Declining corporate investment and a lack of innovation in the development of new antibiotics are weakening efforts to battle drug-resistant illnesses,” according to the World Health Organization (WHO). So, we extended our effort to predict a new natural compound to overcome the resistance of this bacteria. |
format | Online Article Text |
id | pubmed-9460163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94601632022-09-10 In-silico investigation of a novel inhibitors against the antibiotic-resistant Neisseria gonorrhoeae bacteria Mohammed Ali, Hani Saudi J Biol Sci Original Article Antibiotics are drugs that are used to treat or prevent bacterial infections. They work by either killing or stopping bacteria from spreading. Nevertheless, it appeared in the last decade, Antibiotic-resistant bacteria are bacteria resistant to antibiotics and cannot be controlled or killed by them. In the presence of an antibiotic, they can live and even reproduce. The Neisseria gonorrhoeae bacteria is appearing to be a multidrug-resistant pathogen. Many factors contribute to antibiotic resistance, including unfettered access to antimicrobials, incorrect drug selection, misuse, and low-quality antibiotics. Here, we investigated in-silico docking screening and analysis for ten natural marine fungus extracted compounds. The resulted data were examined for the best binding affinity, toxicity, and chemical interactions. The most superior compound was elipyrone A with six hydrogen bonds, −8.5 of binding affinity, and preferable results in the SWISS-ADME examination. It is well known that “Declining corporate investment and a lack of innovation in the development of new antibiotics are weakening efforts to battle drug-resistant illnesses,” according to the World Health Organization (WHO). So, we extended our effort to predict a new natural compound to overcome the resistance of this bacteria. Elsevier 2022-10 2022-08-22 /pmc/articles/PMC9460163/ /pubmed/36091725 http://dx.doi.org/10.1016/j.sjbs.2022.103424 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Mohammed Ali, Hani In-silico investigation of a novel inhibitors against the antibiotic-resistant Neisseria gonorrhoeae bacteria |
title | In-silico investigation of a novel inhibitors against the antibiotic-resistant Neisseria gonorrhoeae bacteria |
title_full | In-silico investigation of a novel inhibitors against the antibiotic-resistant Neisseria gonorrhoeae bacteria |
title_fullStr | In-silico investigation of a novel inhibitors against the antibiotic-resistant Neisseria gonorrhoeae bacteria |
title_full_unstemmed | In-silico investigation of a novel inhibitors against the antibiotic-resistant Neisseria gonorrhoeae bacteria |
title_short | In-silico investigation of a novel inhibitors against the antibiotic-resistant Neisseria gonorrhoeae bacteria |
title_sort | in-silico investigation of a novel inhibitors against the antibiotic-resistant neisseria gonorrhoeae bacteria |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460163/ https://www.ncbi.nlm.nih.gov/pubmed/36091725 http://dx.doi.org/10.1016/j.sjbs.2022.103424 |
work_keys_str_mv | AT mohammedalihani insilicoinvestigationofanovelinhibitorsagainsttheantibioticresistantneisseriagonorrhoeaebacteria |